Cellular and Molecular Pharmacology

CMP Seminars 2013-2014

August 21, 2013
11 AM
Michela Marinelli, Ph.D.
Rosalind Franklin University
North Chicago, IL
Dopamine Neuron Activity and Addiction Risk
October 16, 2013
1 PM
Irene Mazzoni, Ph.D.
World Anti-Doping Agency
Montreal, Canada
The World Anti-Doping Code. Prohibited Substances and Methods in Sport: Present and Future
October 30, 2013
11 AM
Leandro Vendruscolo, Ph.D.
The Scripps Research Institute
La Jolla, CA
Brain Stress Systems and Addiction: Focus on Corticosteroid-dependent Plasticity and Alcoholism 
October 31, 2013
2 PM
Manuel Mameli
French Institute of Health and Medical Research
Paris, France
Cocaine-Evoked Synaptic Plasticity in the Lateral Habenula: Coding for Good or Bad States?
November 5, 2013
11 AM 
 Anna Lee, Ph.D.
University of Texas at Austin
Austin, TX
Regulation of Nicotinic Acetylcholine Receptors in Addiction 
November 18, 2013
11 AM
Nicholas DiPatrizio, Ph.D.
University of California, Irvine
Irvine, CA 
Endocannabinoids and the Neurobiological Control of Dietary Fat Intake 
November 20, 2013
11 AM
Min Zhou, Ph.D.
Ohio State University
Columbus, OH
Unveiling the mystery of astrocyte potassium channels
November 21, 2013
1 PM

December 16, 2013
11 AM
Stephen Mahler, Ph.D.
Medical University of South Carolina
Charleston, SC
Functional-Anatomical Dissection of Neural Circuits Underlying Reward-Related Behaviors
January 9, 2014
11 AM
Joanna Dabrowska, Pharm.D., Ph.D.
Emory University
Atlanta, GA
The Yin and Yang of Stress and Affect – Interactions Between the CRF and Oxytocin Systems

May 13, 2014
11 AM
Asa Abeliovich, M.D., Ph.D.
Columbia University
New York, NY
Modeling Parkinson's Disease Risk
May 28,2014
11 AM
Carlos Bolaños, Ph.D.
Florida State University
Tallahassee, FL
Altering Adult Emotional Behavior: Neurobiological Consequences of Early Life Experiences
June 4, 2014
11 AM
Kathy Steece-Collier, Ph.D.
Michigan State University
Lansing, MI
Target Pathology and Parkinson's Disease Therapeutics